Comparison
Why is Milestone Scientific, Inc. ?
Unrated Stock - No Analysis Available
How much should you hold?
- Overall Portfolio exposure to Milestone Scientific, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
No Data Found
Quality key factors
Factor
Value
Sales Growth (5y)
10.06%
EBIT Growth (5y)
1.88%
EBIT to Interest (avg)
-7.58
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.47
Sales to Capital Employed (avg)
1.53
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
8.76%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
8.21
EV to EBIT
-3.08
EV to EBITDA
-3.16
EV to Capital Employed
9.53
EV to Sales
2.30
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-309.05%
ROE (Latest)
-261.52%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bullish
Technical Movement
21What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -1.82 MM
OPERATING PROFIT(Q)
Highest at USD -0.78 MM
PRE-TAX PROFIT(Q)
Highest at USD -0.84 MM
NET PROFIT(Q)
Highest at USD -0.84 MM
DEBTORS TURNOVER RATIO(HY)
Highest at 5.15 times
OPERATING PROFIT MARGIN(Q)
Highest at -36.08 %
EPS(Q)
Highest at USD -0.01
-7What is not working for the Company
INTEREST(9M)
At USD 0.04 MM has Grown at inf%
DEBT-EQUITY RATIO
(HY)
Highest at -9.15 %
CASH AND EQV(HY)
Lowest at USD 2.31 MM
Here's what is working for Milestone Scientific, Inc.
Operating Cash Flow
Highest at USD -1.82 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Operating Profit
Highest at USD -0.78 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Operating Profit trend is quite positive
Operating Profit (USD MM)
Pre-Tax Profit
Highest at USD -0.84 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD -0.84 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Operating Profit Margin
Highest at -36.08 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
At USD -0.84 MM has Grown at 41.29%
over average net sales of the previous four periods of USD -1.43 MMMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
At USD -0.84 MM has Grown at 41.29%
over average net sales of the previous four periods of USD -1.43 MMMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD -0.01
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Debtors Turnover Ratio
Highest at 5.15 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Milestone Scientific, Inc.
Interest
At USD 0.04 MM has Grown at inf%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Debt-Equity Ratio
Highest at -9.15 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Cash and Eqv
Lowest at USD 2.31 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents






